Procedure for the synthesis of peptide 1
Loading resin: 2-Chlorotrityl chloride resin (300 mg, 1.2 g/mol) was added to a Bio-Rad Poly-Prep column.
The resin was swollen for 15 minutes in CH 2 Cl 2 , and the solvent was drained. A 8 mL solution of BocOrn(Fmoc)-OH (0.6 equiv, 80 mg, 0.22 mmol) in 4% 2,4,6-collidine in CH 2 Cl 2 was added to the resin. The resin was left on a rocker overnight (~16 hours). The solution was drained and a solution of CH 2 Cl 2 /MeOH/DIPEA (17:2:1) was added to the resin to cap unreacted sites. The suspension was rocked for one hour. The solution was drained and transferred into a reaction vessel for synthesizer or handcoupling.
Peptide synthesis: The iterative procedure of Fmoc-deprotection and amino acid coupling was done on the PS3 synthesizer or manually as follows: (1) 
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Cyclization of the peptide: The linear peptide, HOBt (4 equiv), and HBTU (4 equiv) was dissolved in 125 mL DMF and stirred. After 10 minutes of stirring, 0.3 mL of N-methylmorpholine was added to the solution and stirred overnight under N 2 . The solution was concentrated in vacuo to affords the crude cyclic peptide as a yellow oil.
Global deprotection and isolation:
The crude cyclized peptide was dissolved in a 20 mL solution of TFA/TIPS/H 2 O (25:1:1) and stirred for 1 hour. The solution was concentrated in vacuo. The crude peptide was dissolved in 20% ACN in water and filtered through a 0.2 μm syringe filter. The peptide was purified with a C18 column coupled to Beckman preparative HPLC. The fractions were collected over a gradient of 20-60% ACN in water each containing 0.1% TFA. The pure fractions that contained the desired peptide were combined, concentrated in vacuo, frozen, and lyophilized to afford the peptide as a white fluffy solid.
Crystallization procedure for peptide 1
Initial screening: Peptide 1 was screened in 864 crystallization conditions using Hampton Research crystallization kits (Crystal Screen, Index, and PEG/ION). This screen was performed using the hanging drop vapor diffusion method in 96-well plates with three 150-nL drops per well. In each hanging drop, a 10 mg/mL solution of peptide 1 in filtered deionized water (18 MΩ) was combined with the crystallization buffer in 1:1, 1:2, and 2:1 ratio. The 96-well plates were set up with a TTP Labtech Mosquito pipetting robot. The 96-well plates were examined daily under a microscope for next seven days to check for crystal growths.
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Optimization: Crystallization conditions that grew crystals in the initial screening were optimized further in 4x6 Hampton VDX 24-well plates. The hanging drop vapor diffusion method was used. Each well in optimization plates was set up to contain 1 mL of crystallization buffer based on conditions from the initial screening by varying pH and percent co-solvents. Each hanging drop on siliconized glass cover slides from Hampton Research contained of 10 mg/mL solution of peptide 1 in water and crystallization buffer in 1:1 ratio (2 μL drop), 1:2 ratio (3 μL drop), and 2:1 ratio (3 μL drop). The cover slides were inverted and pressed down onto the 24-well plates with silicon grease to provide a sealed environment in each well.
Data collection and data processing:
Data was collected on a Rigaku Micromax-007 HF diffractometer with a Cu rotating anode at 1.54 Å wavelength. The data were integrated, scaled, and merged using iMosflm. Hybrid structure search (HySS) in the Phenix software suite was used to determine the coordinates of the anomalous signal. The electron density maps were generated using the coordinates of the iodine anomalous signal as initial positions in Autosol. Manipulation of the model coordinates was done in Coot.
Models were refined with phenix.refine. Table S1 shows the refinement statistics for peptide 1. 
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Thioflavin T fluorescence assays of peptide 1
Thioflavin T (ThT) fluorescence assays were used to monitor the aggregation of peptide 1. Peptide 1 was suspended in aqueous solutions of H 2 O, 100 mM NaOAc at pH 5.3, and 1X Tris buffered saline (TBS) in the presence of ThT. ThT fluorescence was monitored over 24 hours at 37°C using a fluorescence plate reader. The peptide did aggregate in TBS, indicated by elevated fluorescence, but did not aggregate in H 2 O or in 100 mM NaOAc, which is similar to the crystallization condition. In TBS, the ThT-active species started to form after 4 hours of incubation and plateaued after 9 hours. These data show that peptide 1 can aggregate to form ThT-active species in aqueous solution, which might resemble the extended β-sheets observed in the X-ray crystallographic structure.
The Tris, 100 mM NaCl, pH 7.5), or 100 mM NaOAc. Five replicate runs were performed to ensure reproducibility. 
